Luminex received FDA Emergency Use Authorization and CE Mark for expanded NxTAG panel test Including SARS-CoV-2
On Mar. 4, 2021, Luminex announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…
-
-
Biotechnology | COVID-19 | Disease | Oncology
Men, older adults and smokers more prone to infection by SARS-CoV-2
On Mar. 3, 2021, TGen, an affiliate of City of Hope announced that an in-depth analysis of the…
-
FDA allowed more flexible storage, transportation conditions for Pfizer-BioNTech COVID-19 vaccine
On Feb. 25, 2021, the U.S. Food and Drug Administration announced that it was allowing undiluted frozen vials…
-
Johnson & Johnson announces submission to WHO for EUL of investigational single-shot COVID-19 vaccine candidate
On Feb. 19, 2021, Johnson & Johnson announced that Janssen-Cilag had submitted for Emergency Use Listing (EUL) to…
-
CureVac and UK Government announced collaboration on development of vaccines against SARS-CoV-2 variants
On Feb. 5, 2021, CureVac announced that it had entered a collaboration with the UK Government to develop…
-
Oxford University vaccine effective against major B117 ‘Kent’ coronavirus strain circulating in the UK
On Feb. 5, 2021, Oxford University announced that a preprint of ongoing work to assess effectiveness of Oxford’s…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Therapeutics | Vaccine | WHO
WHO welcomed $90 million contribution from Kingdom of Saudi Arabia to support COVID-19 global response
On Oct. 2, 2020, the World Health Organization (WHO) and the Kingdom of Saudi Arabia signed a contribution…
-
Lenzilumab COVID-19 case-control study published in Mayo Clinic Proceedings Journal
On Sept. 3, 2020, Humanigen announced the first case-control data of lenzilumab in severe COVID-19 demonstrated an 80%…
-
Gilead submited New Drug Application to FDA for Veklury (Remdesivir) for treatment of COVID-19
On Aug. 10, 2020, Gilead Sciences announced that it had submitted a New Drug Application (NDA) to the…
-
Vir and Alnylam identified RNAi therapeutic development candidate, VIR-2703 (ALN-COV), targeting SARS-CoV-2 for treatment of COVID-19
On May 4, 2020, Vir Biotech and Alnylam Pharma announced the selection of a development candidate for VIR-2703,…
-
Roche’s COVID-19 antibody test received FDA Emergency Use Authorization and is available in markets accepting the CE mark
On May 2, 2020, Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency…
-
Gilead announced investigational antiviral remdesivir received FDA Emergency Use Authorization for treatment of COVID-19
On May 1, 2020, Gilead announced that the U.S. Food and Drug Administration (FDA) has granted emergency use…
-
CDC launched national viral genomics consortium to better map SARS-CoV-2 transmission
On May 1, 2020, the U.S. Centers for Disease Control and Prevention (CDC) launched the SARS-CoV-2 Sequencing for…
-
Moderna and Lonza announced worldwide strategic collaboration to manufacture Moderna’s Vaccine (mRNA-1273) against novel Coronavirus
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
-
Mateon announced peer reviewed publication on its R&D effort against COVID-19
On Apr. 30, 2020, Mateon Therapeutics report several peer-reviewed publications derived from its R&D effort against COVID-19. Published April…
-
ViralClear published comparative in vitro data on merimepodib and remdesivir activity against COVID-19 novel Coronavirus in F1000 research
On Apr. 30, 2020, BioSig Technologies announced that an article titled, ‘The IMPDH inhibitor merimepodib has similar antiviral…
-
NIH’s axing of bat coronavirus grant a ‘horrible precedent’ and might break rules, critics say
On Apr. 30, 2020, the research community reacted with alarm and anger to the National Institutes of Health’s…
-
Gilead announced results from phase 3 trial of investigational antiviral Remdesivir in patients with severe COVID-19
On Apr. 29, 2020, Gilead announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and…
-
Entos Pharmaceuticals partnered with EpiVax to develop a pan-Coronavirus DNA vaccine
On Apr. 28, 2020, Entos Pharmaceuticals announced a collaboration with EpiVax, a world leading informatics and immunology biotechnology…
-
Dutch consortium began production of millions of medical face masks for healthcare professionals in the Netherlands
On Apr. 28, 2020, the Dutch consortium of AFPRO Filters, Royal Auping, and Royal DSM has begun large-scale…
-
Secarna Pharma entered into cooperation with Guangzhou’s Sun Yat-sen University to develop treatment for SARS-CoV-2 viral infections
On Apr. 28, 2020, Secarna Pharmaceuticals announced that the Company had entered into a cooperation with the First…
-
Six COVID-19 patients treated with RedHills opaganib under compassionate use show objective clinical improvement
On Apr. 27, 2020, RedHill Biopharma provided an additional update on the compassionate use program with its investigational…
-
Regeneron and Sanofi updated phase 2/3 adaptive-designed trial of Kevzara (sarilumab) in hospitalized COVID-19 patients
On Apr. 27, 2020, Regeneron and Sanofi announced preliminary results from the Phase 2 portion of an ongoing…
-
Ichor announced its TriGrid Delivery System is being utilized for delivery in non-human primates of a COVID-19 DNA vaccine being developed by Naval Medical Research Center
On Apr. 27, 2020, Ichor announced that its clinical stage TriGrid® Delivery System (TriGrid) is being utilized for…
-
WHO reported “no evidence” that recovered COVID-19 patients cannot be reinfected
On Apr. 25, 2020, the World Health Organization (WHO) reported there was currently ‘no evidence’ that people who…
-
CIRM Board funded first clinical study for COVID-19
On Apr. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $749,999 to…
-
Keck Foundation gifted $4 million to USC to speed public health and research on COVID-19
On Apr. 24, 2020, the W. M. Keck Foundation announced a $4 million gift that will help scientists…
-
Coronavirus drifts through the air in microscopic droplets – here’s the science of infectious aerosols
On Apr. 24, 2020, Shelly Miller, Professor of Mechanical and Environmental Engineering, University of Colorado Boulder, reported that…
-
Mayo Clinic partnered with state of Minnesota, University of Minnesota on breakthrough COVID-19 initiative
On Apr. 23, 2020, the Mayo Clinic, Minnesota Department of Health and University of Minnesota announced a breakthrough…
-
Federal funding for rapid COVID-19 test goes to McKelvey Engineering researchers
On Apr. 22, 2020, Engineers at the McKelvey School of Engineering at Washington University in St. Louis announced…
